Fortrea Completes $45 Mln Acquisition Of Worldwide's Early Phase Services Divisions
(RTTNews) - Fortrea Holdings Inc. (FTRE), a global contract research organization (CRO), announced the completion of its $45 million all-cash acquisition of the Early Phase Services division of Worldwide Clinical Trials.